06 | Nirsevimab as a key strategy to prevent respiratory syncytial virus among newborns and children: real-world evidence from Italy and Sicily. EuroMed Bio J [Internet]. 2026 Nov. 10 [cited 2026 Nov. 12];21(s1). Available from: https://www.embj.org/home/article/view/671